| Complement and coagulation cascades |
2.01 |
0.00e+0 |
76/85 (89.41%) |
SERPINA1;TFPI;F5;...
|
| Fanconi anemia pathway |
1.90 |
2.13e-2 |
36/54 (66.67%) |
BRCA1;RMI1;USP1;...
|
| DNA replication |
1.87 |
1.42e-2 |
34/36 (94.44%) |
MCM3;FEN1;RFC4;...
|
| Mismatch repair |
1.84 |
1.42e-2 |
22/23 (95.65%) |
MSH6;RFC4;MSH2;...
|
| Butanoate metabolism |
1.81 |
1.70e-2 |
23/28 (82.14%) |
ACAT1;ACSM3;HMGCS1;...
|
| Glyoxylate and dicarboxylate metabolism |
1.80 |
1.42e-2 |
23/30 (76.67%) |
GRHPR;ACAT1;SHMT1;...
|
| Ascorbate and aldarate metabolism |
1.80 |
1.22e-2 |
15/30 (50%) |
UGDH;UGT2B28;UGT2B4;...
|
| Homologous recombination |
1.75 |
2.22e-2 |
35/41 (85.37%) |
BRCA1;MRE11;POLD4;...
|
| Wnt signaling pathway |
1.73 |
2.68e-2 |
124/166 (74.7%) |
LEF1;LGR5;BAMBI;...
|
| Pantothenate and CoA biosynthesis |
1.71 |
3.12e-2 |
14/21 (66.67%) |
DPYS;AASDHPPT;DPYD;...
|
| NF-kappa B signaling pathway |
-1.63 |
4.06e-2 |
90/104 (86.54%) |
TRIM25;BCL2A1;CCL4;...
|
| Leishmaniasis |
-1.63 |
4.10e-2 |
67/77 (87.01%) |
NOS2;ELK1;JUN;...
|
| Caffeine metabolism |
-1.64 |
3.91e-2 |
5/6 (83.33%) |
NAT1;XDH;CYP2A6;...
|
| Human cytomegalovirus infection |
-1.66 |
3.19e-2 |
201/225 (89.33%) |
RAC2;BAK1;GNG4;...
|
| Chagas disease |
-1.66 |
3.31e-2 |
93/102 (91.18%) |
FOS;MAPK1;AKT3;...
|
| RIG-I-like receptor signaling pathway |
-1.67 |
3.34e-2 |
64/70 (91.43%) |
CYLD;ISG15;MAP3K1;...
|
| Chemokine signaling pathway |
-1.67 |
3.47e-2 |
163/192 (84.9%) |
GNG10;CCL7;STAT5B;...
|
| Lipid and atherosclerosis |
-1.67 |
3.33e-2 |
190/215 (88.37%) |
CYP2A6;SELE;APOA4;...
|
| Kaposi sarcoma-associated herpesvirus infection |
-1.67 |
3.36e-2 |
172/193 (89.12%) |
MICA;BAK1;GNG4;...
|
| Morphine addiction |
-1.68 |
3.39e-2 |
80/91 (87.91%) |
GNAI2;GNG3;PDE4C;...
|
| Tuberculosis |
-1.68 |
3.49e-2 |
159/180 (88.33%) |
RAB7A;CTSS;NOS2;...
|
| Antigen processing and presentation |
-1.70 |
3.24e-2 |
60/78 (76.92%) |
TAPBP;KIR2DL1;HLA-DRB1;...
|
| Measles |
-1.70 |
3.42e-2 |
133/139 (95.68%) |
APAF1;AKT2;CD46;...
|
| Autoimmune thyroid disease |
-1.74 |
2.25e-2 |
46/53 (86.79%) |
IFNA21;GZMB;HLA-DOA;...
|
| Pertussis |
-1.74 |
2.31e-2 |
64/76 (84.21%) |
CXCL6;NOS2;JUN;...
|
| Pathogenic Escherichia coli infection |
-1.76 |
2.00e-2 |
152/197 (77.16%) |
MYO1F;JUN;TUBB;...
|
| Toll-like receptor signaling pathway |
-1.77 |
2.15e-2 |
94/104 (90.38%) |
IFNAR2;TLR1;JUN;...
|
| NOD-like receptor signaling pathway |
-1.77 |
2.21e-2 |
145/181 (80.11%) |
MFN2;TXN;DEFA6;...
|
| Toxoplasmosis |
-1.79 |
1.82e-2 |
103/112 (91.96%) |
HLA-DOA;GNAI2;CD40LG;...
|
| Amoebiasis |
-1.82 |
1.49e-2 |
99/102 (97.06%) |
LAMA2;LAMC3;IL1R2;...
|
| Thyroid hormone synthesis |
-1.82 |
1.50e-2 |
66/75 (88%) |
CREB3L1;ATP1A1;SLC26A4;...
|
| Endocytosis |
-1.83 |
1.37e-2 |
198/252 (78.57%) |
ARPC3;CLTC;GRK3;...
|
| Legionellosis |
-1.86 |
1.03e-2 |
51/57 (89.47%) |
ARF1;CASP7;BNIP3;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
-1.88 |
7.81e-3 |
62/70 (88.57%) |
JUN;MAPK8;ATP6V0D1;...
|
| TNF signaling pathway |
-1.90 |
6.84e-3 |
103/112 (91.96%) |
JUNB;CREB3L2;CX3CL1;...
|
| Salmonella infection |
-1.91 |
8.20e-3 |
198/249 (79.52%) |
HRAS;FLNC;TXN;...
|
| Cytokine-cytokine receptor interaction |
-1.94 |
3.42e-3 |
246/295 (83.39%) |
LTBR;TNFRSF11A;IL17A;...
|
| Rheumatoid arthritis |
-1.96 |
4.56e-3 |
78/93 (83.87%) |
CTLA4;TNFRSF11A;IL17A;...
|
| Protein processing in endoplasmic reticulum |
-1.96 |
6.84e-3 |
127/171 (74.27%) |
OS9;SSR2;DNAJB2;...
|
| Viral protein interaction with cytokine and cytokine re... |
-2.11 |
0.00e+0 |
84/100 (84%) |
CX3CL1;CCR3;CXCL6;...
|
